Potassium iodide

Active ingredient description

Potassium iodide is indicated as a thyroid-blocking agent to prevent the uptake of radioactive iodine, for example after a nuclear accident or during a nuclear medicine investigation before administering a radioiodinated compound, which is metabolised to iodide or which contains radioiodine impurities.

Medicine classification

This medicinal substance has been classified in the anatomical therapeutic chemical (ATC) classification according to its main therapeutic use as follows:

ATC code
Group title
Classification
Potassium iodide
R Respiratory system → R05 Cough and cold preparations → R05C Expectorants, excl. combinations with cough suppressants → R05CA Expectorants
Discover more medicines within R05CA02
Potassium iodide
S Sensory organs → S01 Ophthalmologicals → S01X Other ophthalmologicals → S01XA Other ophthalmologicals
Discover more medicines within S01XA04
Potassium iodide
V Various → V03 All other therapeutic products → V03A All other therapeutic products → V03AB Antidotes
Discover more medicines within V03AB21

Medicines

Potassium iodide is the active ingredient of these drugs:

Drug
Countries

Hong Kong

Germany

Austria Germany

Germany

Lithuania

United Kingdom

Cyprus Spain

Spain

Potassium iodide is also found within below combination drugs:

ADDAMEL , ADDAVEN , ADDITRACE , EXPEC , GEMSTAIN , JODTHYROX , JUNIMIN , JUNYELT , NATIFAR , NUTRITRACE , NUTRYELT , SUPPLIVEN , TENTIL , THYRONAJOD , TRACUTIL , YODOCEFOL , YODUK COMPLEX , YOFOLVIT

Product monographs

Medicine agencies around the world have authorized marketing of this active ingredient according to these medication package inserts (MPIs):

Title
Type
Country
Summary of product characteristics (SPC)
UK

Structural formula

Graphic representation of the active ingredient's molecular structure

Unique ingredient identifier (UNII)

1C4QK22F9J - POTASSIUM IODIDE

CAS registry number

7681-11-0 - Potassium iodide

SNOMED-CT

89351005 - Potassium iodide (substance)